Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Nasdaq Biotechnology Ishares ETF
(NQ:
IBB
)
161.71
USD
-0.16 (-0.10%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Nasdaq Biotechnology Ishares ETF
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Has the Market Baked a Mud Pie or Fudge Cake?
July 05, 2016
Our Granddad Russell 2000, which ended last week managed to hang onto the 50 daily moving average. If you hope to lick the mixing spoon, it’s this index that gives you the best chance for a sweet...
Tags
ETF's
From
Blogs - TalkMarkets
Large Cap Biopharmaceuticals-Valuation Models 2016
July 03, 2016
The biotech sector has underperformed the market because of the severe correction in August/September of 2015 followed by another downdraft in January 2016 all the result of “bubble” valuations.
Tags
Stocks / Equities
ETF's
Pharma/Biotech
From
Blogs - TalkMarkets
Pockets Filled With Gold
July 02, 2016
Last week’s market saw its own version of a gold rush. Cash gold ended above the 200 week moving average for the second week in a row. The last time it traded above that moving average was in April...
Tags
Commodities
Gold/Precious Metals
Stocks / Equities
From
Blogs - TalkMarkets
Utilities, Anyone?
July 01, 2016
The celebratory nature of the stock market is being masked by another telling trend: Defensive sectors are outperforming higher risk areas.
Tags
Stocks / Equities
Utilities
ETF's
From
Blogs - TalkMarkets
Fast Money Traders Share Their Biotech Picks
July 01, 2016
On CNBC's Fast Money Final Trade, Tim Seymour said that Gilead Sciences, Inc. (NASDAQ: GILD) looks cheap at 7 times price-to-earnings ...
Tags
GILD
Guy Adami
IBB
From
Benzinga
Traders spot relative value in biotech
June 30, 2016
The iShares NASDAQ Biotechnology ETF was up more than 3 percent on the week, but down nearly 24 percent this year.
Tags
Pfizer Inc
Investing
Biotechnology
From
CNBC.com News
The Best Seasonal Investments For Q3
June 30, 2016
Bonds and defensive baskets offer the strongest seasonal tailwinds in Q3.The best industries for Q3 seasonality are biotech, healthcare providers, and software.
Tags
ETF's
Bonds
From
Blogs - TalkMarkets
Vista Partners Initiates Coverage on Mount TAM Biotechnologies, Inc. (Ticker: MNTM); $3.25 Price Target
June 30, 2016
From
Marketwired News Releases
BRexit Bottom For Biotech Creates Buying Opportunity
June 29, 2016
Biotech stocks soared yesterday getting relief from the brutal BRexit bashing that scared away all buyers. BRexit has little to do with biopharma but the”risk-off” pall brings caution and a move to...
Tags
ETF's
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Don't Put Away Your Umbrella Just Yet
June 29, 2016
Yesterday’s potential reversal pattern in its current Bearish phase confirmed today. QQQs ran up to the January 13th high the day it opened higher and then proceeded to tank. It also ran slightly above...
Tags
Pharma/Biotech
Gold/Precious Metals
ETF's
From
Blogs - TalkMarkets
How Do I Turn Off All The Noise?
June 28, 2016
As I went through the tweets of those I follow before the market opened today, I literally felt like my head could explode. Opinions, opinions, opinions and more opinions.
Tags
ETF's
Stocks / Equities
Currencies/Forex
From
Blogs - TalkMarkets
Brexit: A Bane for Bumbling Biotech ETFs?
June 28, 2016
Brexit is the excuse of the moment that many market observers are pointing to explain the near-term struggles of various asset classes and sectors. In some cases, that observation is accurate. In...
Tags
featured
biotech
IBB
From
ETF Trends
Brexit brings an opportunity to reload the portfolio
June 24, 2016
Assuming that a few of our favorite names take a hit this morning, we should be able to pick up some shares at a nice discount, which is the smart play when investors are panicking.
Tags
FIT
Telecommunications
IBB
From
MarketWatch
The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery
June 24, 2016
Tags
NASDAQ:IBB
NASDAQ:CELG
NASDAQ:BIIB
From
InvestorPlace
Analysts Anticipate IBB Will Reach $359
June 24, 2016
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Best Stock Charts - June 23, 2016
June 23, 2016
We talk about the latest market overview by reviewing different charts.
Tags
Stocks / Equities
Energy
Currencies/Forex
From
Blogs - TalkMarkets
The iShares Nasdaq Biotechnology Index (ETF) (IBB): Gravity Calls!
June 23, 2016
Tags
Trading Advice
NASDAQ:IBB
From
InvestorPlace
Sharp Biotech Reversal To Upside Today: IBB Up 2.40%…Update-1
June 22, 2016
The IBB peaked at $260 and dropped back to settle at $256.56 up only 0.56%.
Tags
ETF's
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Biotech stocks surge as Medicare report relieves worries
June 22, 2016
Biotech stocks rallied after a government report said that Medicare cost-cutting measures will not be triggered this year.
Tags
Investing
Celgene Corp
iShares Nasdaq Biotechnology ETF
From
CNBC.com News
Here Is Why Biotech Stocks Just Exploded Higher
June 22, 2016
On the back of extremely heavy volume, Biotech and Pharma stocks soared moments ago, following yesterday's surprising weakness. What was the catalyst?
Tags
ETF's
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
Biotechs Are Ripping Following IPAB Ruling
June 22, 2016
Biotech stocks spiked higher on Wednesday after the U.S. government said that Medicare will be exhausted in 2028, two years sooner ...
Tags
News
AMGN
ACAD
From
Benzinga
Troubling Technical News for Biotech ETFs
June 22, 2016
Already under significant pressure, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotech exchange traded funds face a predictable result...
Tags
featured
IBB
SBIO
From
ETF Trends
Bio Tech - Market Leadership Testing Breakdown Level
June 21, 2016
Bio-Tech IBB could be forming a “Bearish Descending Triangle. Bio-Tech was tons stronger than the broad markets from 2011 to 2015.
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
Blogs - TalkMarkets
Biotech ETFs Reeling in Longest Sector Selloff in Two Decades
June 21, 2016
Biotechnology-related exchange traded funds are stuck in a malaise, with the underlying biotech sector declining for the ninth consecutive session, its longest selloff in a twenty years. Since June 6,...
Tags
IBB
BIIB
Biotechnology
From
ETF Trends
Biotech Bloodbath: Ditch XBI, IBB for Now
June 21, 2016
Tags
NASDAQ:IBB
NYSE:VRX
Trading Advice
From
InvestorPlace
Expect More Election Year Volatility For Biotech ETFs
June 21, 2016
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have disappointed investors for close to a year. Unfortunately, election...
Tags
IBB
XBI
FBT
From
ETF Trends
Vista Partners Publishes June 2016 Macroeconomic & Investment Newsletter
June 21, 2016
Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Big Data, Biotechnology, Fintech, Healthcare, IoT, SaaS, Sports, WearableTech & More
From
Marketwired News Releases
ETF TMI: Strategy Shares Debuts Two ETFs; Global Markets on Fire
June 20, 2016
Got a case of TMI (Too Much Information)? ETF Trends takes a condensed look at latest happenings… Strategy Shares Debuts with Two Actively Managed ETFs Strategy Shares on Thursday announced its launch,...
Tags
XBI
IBB
HYG
From
ETF Trends
Biotech Blahs: Unable To Hold Gains After ASCO Run-Up
June 17, 2016
As of midday trading Friday biotech stocks are trading down near the May lows erasing gains from the ASCO run-up. Nonetheless, there is plenty of interest in the sector with tons of cash waiting in the...
Tags
Pharma/Biotech
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Follow Icahn Into Allergan Stock
June 17, 2016
Carl Icahn has just declared that he has invested a mint into Allergan. Investors should follow suit and when the Teva deal goes through, Allergan will have a cool $20 billion extra in liquidity to...
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
< Previous
1
2
...
93
94
95
96
97
98
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.